These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26638161)

  • 1. Pharmacokinetic properties of low-dose SoluMatrix meloxicam in healthy adults.
    Hussaini A; Solorio D; Young C
    Clin Rheumatol; 2016 Apr; 35(4):1099-104. PubMed ID: 26638161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.
    Desjardins PJ; Olugemo K; Solorio D; Young CL
    Clin Ther; 2015 Feb; 37(2):448-61. PubMed ID: 25499666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers.
    Tangsucharit P; Kampan J; Kanjanawart S; Gaysonsiri D; Vannaprasaht S; Tiamkao S; Phunikhom K; Simasathiansophon S; Puapairoj P; Tassaneeyakul W
    Int J Clin Pharmacol Ther; 2009 Oct; 47(10):638-42. PubMed ID: 19825327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study.
    Altman R; Hochberg M; Gibofsky A; Jaros M; Young C
    Curr Med Res Opin; 2015 Dec; 31(12):2331-43. PubMed ID: 26503347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and safety of low-dose submicron indomethacin 20 and 40 mg compared with indomethacin 50 mg.
    Olugemo K; Solorio D; Sheridan C; Young CL
    Postgrad Med; 2015 Mar; 127(2):223-31. PubMed ID: 25639879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the formulation on the bioequivalence of meloxicam: tablet and suspension.
    Helmy SA; El Bedaiwy HM
    Drug Res (Stuttg); 2013 Jul; 63(7):331-7. PubMed ID: 23619819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of meloxicam.
    Türck D; Busch U; Heinzel G; Narjes H
    Arzneimittelforschung; 1997 Mar; 47(3):253-8. PubMed ID: 9105543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and bioequivalence study of meloxicam tablets in healthy male subjects.
    Gschwend MH; Erenmemişoğlu A; Martin W; Tamur U; Kanzik I; Hincal AA
    Arzneimittelforschung; 2007; 57(5):264-8. PubMed ID: 17598697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioequivalence studies of two brands of meloxicam tablets in healthy Pakistani volunteers.
    Hasan SM; Shoaib MH; Hassan F; Rehman IU
    Pak J Pharm Sci; 2009 Apr; 22(2):199-204. PubMed ID: 19339233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence study of a novel orodispersible tablet of meloxicam in a porous matrix after single-dose administration in healthy volunteers.
    Radicioni M; Connolly S; Stroppolo F; Granata G; Loprete L; Leuratti C
    Int J Clin Pharmacol Ther; 2013 Mar; 51(3):234-43. PubMed ID: 23380429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and adverse effects of oral meloxicam tablets in healthy adult horses.
    Vander Werf KA; Davis EG; Kukanich B
    J Vet Pharmacol Ther; 2013 Aug; 36(4):376-81. PubMed ID: 23067209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of meloxicam in healthy Chinese volunteers].
    Xu HY; Zhong DF; Zhao LM; Zhang YF; Zhang BJ
    Yao Xue Xue Bao; 2001 Jan; 36(1):71-3. PubMed ID: 12579866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and bioequivalence of 2 meloxicam oral dosage formulations in healthy adult horses.
    Vivancos M; Barker J; Engbers S; Fischer C; Frederick J; Friedt H; Rybicka JM; Stastny T; Banse H; Cribb AE
    Can Vet J; 2015 Jul; 56(7):730-6. PubMed ID: 26130835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tolerability of meloxicam after i.m. administration.
    Narjes H; Türck D; Busch U; Heinzel G; Nehmiz G
    Br J Clin Pharmacol; 1996 Feb; 41(2):135-9. PubMed ID: 8838440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of Meloxicam Tablets in Healthy Chinese Adults in the Fasting and Fed States: A Single-Site, Single-Dose, Randomized, Open, 2-Period, 2-Sequence, Crossover Bioequivalence Study.
    Yu J; Wang Y; Wu Y; Lin S; Hao R; Fang L; Zhu J; Zhao D; Tong S; Si Y; Ye T; Wu Z; Huang H; Zhou F; Wang Y
    Clin Pharmacol Drug Dev; 2022 Jan; 11(1):71-79. PubMed ID: 34137514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SoluMatrix® Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative Pain.
    Argoff C; McCarberg B; Gudin J; Nalamachu S; Young C
    Pain Med; 2016 Oct; 17(10):1933-1941. PubMed ID: 26995799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and safety of single and multiple oral doses of meloxicam in adult horses.
    Noble G; Edwards S; Lievaart J; Pippia J; Boston R; Raidal SL
    J Vet Intern Med; 2012; 26(5):1192-201. PubMed ID: 22860573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of meloxicam in adult goats: a comparative study of subcutaneous, oral and intravenous administration.
    Karademir U; Erdogan H; Boyacioglu M; Kum C; Sekkin S; Bilgen M
    N Z Vet J; 2016 May; 64(3):165-8. PubMed ID: 26612429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of meloxicam in rabbits after oral administration of single and multiple doses.
    Fredholm DV; Carpenter JW; KuKanich B; Kohles M
    Am J Vet Res; 2013 Apr; 74(4):636-41. PubMed ID: 23531074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.